NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Non-Small Cell Lung Cancer, Lung Cancer, Cancer

Interventions: No intervention

Countries: China

The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Histologically/cytologically confirmed, unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
* Received at least one anti-cancer treatment targeting unresectable Stage IIIB or IV NSCLC in the study site after study initiation
* Radiographic evidence of disease

Exclusion Criteria:

* Prior systematic treatment for unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
* Participation in any anti-cancer, regimen-specified clinical study of first-line treatment for unresectable Stage IIIB or IV NSCLC.

Locations (11)

Beijing, China
Changchun, China
Chengdu, China
Chongqing, China
Fuzhou, China
Harbin, China
Nanning, China
Shanghai, China
Shanghai, China
Wuhan, China
Xi'an, China